Seeing Is Believing
Currently out of the existing stock ratings of Jack Meehan, 33 are a BUY (56.9%), 13 are a HOLD (22.41%), 12 are a SELL (20.69%).
Analyst Jack Meehan, currently employed at BARCLAYS, carries an average stock price target met ratio of 98.72% that have a potential upside of 17.07% achieved within 226 days.
Jack Meehan’s has documented 129 price targets and ratings displayed on 13 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on ILMN, Illumina at 14-Aug-2024.
Analyst best performing recommendations are on INMD (INMODE LTD).
The best stock recommendation documented was for INMD (INMODE LTD) at 11/6/2019. The price target of $22.5 was fulfilled within 5 days with a profit of $3.07 (15.8%) receiving and performance score of 31.6.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$90
$16.81 (22.97%)
$90
16 days ago
(19-Dec-2024)
14/24 (58.33%)
$18.6 (26.05%)
168
Hold
22 days ago
(13-Dec-2024)
8/8 (100%)
$7 (12.28%)
205
Buy
$87
$13.81 (18.87%)
$90
1 months 30 days ago
(05-Nov-2024)
2/9 (22.22%)
$7.24 (9.08%)
43
Buy
$95
$21.81 (29.80%)
$88
1 months 30 days ago
(05-Nov-2024)
3/8 (37.5%)
$15.24 (19.11%)
270
Buy
$90
$16.81 (22.97%)
$93
2 months 27 days ago
(08-Oct-2024)
3/6 (50%)
$9.74 (12.14%)
191
Which stock is Jack Meehan is most bullish on?
What Year was the first public recommendation made by Jack Meehan?